Tailored Outsourcing Solutions Deliver Better Outcomes

As the pharmaceutical industry continues its pursuit of more successful outcomes at all stages of the pharmaceutical pipeline, greater value is coming from outsourcing strategies that provide more comprehensive, adaptable and tightly integrated solutions that are tailored to the industry’s evolving challenges. By selecting an outsourcing provider that has experienced process chemists as well as the ability to integrate small-scale, non-GMP supply with slightly larger scale GMP projects, the outcomes needed by the healthcare and related industries can be met.

GMPs are a foundation of the AMRI SMARTSOURCING philosophy. The scale and range of capabilities at AMRI’s European site places it in the heart of the complete AMRI SMARTSOURCING range of offerings, from discovery to large-scale manufacture. The site has kilo lab-, pilot plant- and large-scale manufacturing capabilities that can scale batch sizes from tens of grams to hundreds of kilos. This includes pre-clinical and Phase I–III product development and commercial manufacturing for approved products.

AMRI is a global contract research and manufacturing organisation that provides services in North America, Europe and Asia. The company’s UK-based site in Holywell offers a combination of process research, process development and commercial manufacturing services, which are co-located with the supporting disciplines of organic chemistry, analytical chemistry and chemical engineering to ensure maximum flexibility and rapid response. In addition, the close integration of facilities and strategically positioned leadership drive synergies between all of AMRI’s manufacturing locations to improve quality, efficiency and delivery of APIs for customers.

Albany Molecular Research, Inc. (AMRI), +1 518 512 2512, www.amriglobal.com.